Abstract Details

Title Is Hemoglobin A1c (HbA1C) Level an Independent Predictor of Adverse Outcomes in Patients with Acute Ischemic Stroke undergoing Endovascular Treatment?

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 239

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Abeer Alsalamah (Prince Sultan Military Medical City) PRESENTER	No disclosure on file
	No disclosure on file
Taqi T. Zafar, MD (SUNY Health Science Center, Upstate)	No disclosure on file
	No disclosure on file
Ali Saeed, MD	No disclosure on file
Mohammad Owais, MD (Baptist Health)	No disclosure on file
	No disclosure on file
Vikram Jadhav, MD (Minnesota Stroke Network)	No disclosure on file
	No disclosure on file
Syed I. Hussain, MD (Cleveland Clinic Abu Dhabi)	Dr. Hussain has nothing to disclose.
Hamza I. Maqsood, MD (Dept of Neurology)	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.